Sputum MMP-12 concentration and enzyme activity in COPD and asthma in relation to smoking status and disease severity Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Effect of smoking cessation on sputum HNP levels in COPD patients and asymptomatic smokers Source: Annual Congress 2008 - Towards smoking cessation Year: 2008
Relationship between vitamin A and inflammation in the sputum and serum of smokers and COPD patients Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Does the infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation? Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
Elevation of surfactant protein A in plasma and sputum in cigarette smokers Source: Eur Respir J 2011; 38: 277-284 Year: 2011
The concentration of α1 - PI and elastase in the blood serum in patients with COPD in the dependence from the stadium of the disease and smoking of the tobacco Source: Eur Respir J 2004; 24: Suppl. 48, 373s Year: 2004
Leptin levels in induced sputum from patients with COPD are sensitive to smoking status Source: Eur Respir J 2005; 26: Suppl. 49, 660s Year: 2005
Effects of one year smoking cessation on inflammation in induced sputum of smokers with and without COPD Source: Eur Respir J 2002; 20: Suppl. 38, 583s Year: 2002
Increased sputum concentrations of total glutathion in patients with COPD who quit smoking Source: Eur Respir J 2001; 18: Suppl. 33, 365s Year: 2001
Measurement of neutrophil activity following acute cigarette smoking in heavy smokers with and without COPD Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007
Physical status and dependence levels in patients with COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014
Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016
Cellular composition of bronchial brush-biopsies in dependence on smoking and etiology of COPD exacerbation Source: Eur Respir J 2007; 30: Suppl. 51, 403s Year: 2007
Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009